| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Officer | Mar 21, 2024 | Sale | $7.68 | 4,578 | 35,159 | 177,474 | Mar 25, 2024, 09:40 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | Oct 13, 2023 | Option Exercise | $4.04 | 864 | 3,491 | 113,377 | Oct 13, 2023, 08:29 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | Mar 16, 2023 | Option Exercise | $8.27 | 2,769 | 22,900 | 112,662 | Mar 20, 2023, 09:08 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | Dec 27, 2022 | Option Exercise | $9.44 | 187 | 1,765 | 106,531 | Dec 29, 2022, 08:56 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | Dec 27, 2022 | Option Exercise | $9.44 | 10,784 | 101,801 | 105,968 | Dec 28, 2022, 09:34 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | Dec 27, 2022 | Option Exercise | $5.09 | 20,000 | 101,800 | 116,752 | Dec 28, 2022, 09:34 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | Jul 19, 2022 | Option Exercise | $8.40 | 405 | 3,402 | 96,752 | Jul 20, 2022, 04:01 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | Mar 16, 2022 | Option Exercise | $7.97 | 1,497 | 11,931 | 92,578 | Mar 18, 2022, 04:03 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | Feb 15, 2022 | Option Exercise | $8.42 | 357 | 3,006 | 88,075 | Feb 17, 2022, 04:05 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | Dec 27, 2021 | Option Exercise | $9.74 | 187 | 1,821 | 87,249 | Dec 29, 2021, 04:17 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | Dec 20, 2021 | Option Exercise | $9.24 | 144 | 1,331 | 86,686 | Dec 22, 2021, 04:03 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | Dec 15, 2021 | Option Exercise | $8.80 | 4,171 | 36,705 | 86,255 | Dec 17, 2021, 04:02 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | Dec 15, 2021 | Option Exercise | $3.67 | 10,000 | 36,700 | 90,426 | Dec 17, 2021, 04:02 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | Jul 20, 2021 | Option Exercise | $19.20 | 392 | 7,526 | 80,426 | Jul 21, 2021, 04:16 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP of Clin. & Trans. Sciences | Apr 28, 2021 | Option Exercise | $2.86 | 10,000 | 28,600 | 78,082 | Apr 30, 2021, 04:10 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Translational Sc | Feb 17, 2021 | Option Exercise | $18.70 | 1,864 | 34,857 | 68,082 | Feb 18, 2021, 05:26 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Translational Sc | Dec 29, 2020 | Sale | $17.81 | 371 | 6,608 | 63,240 | Dec 30, 2020, 05:33 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Translational Sc | Dec 21, 2020 | Sale | $16.42 | 147 | 2,414 | 62,111 | Dec 22, 2020, 03:22 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Translational Sc | Dec 15, 2020 | Option Exercise | $16.50 | 4,373 | 72,155 | 61,683 | Dec 17, 2020, 04:41 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Translational Sc | Dec 15, 2020 | Option Exercise | $4.81 | 15,000 | 72,150 | 66,056 | Dec 17, 2020, 04:41 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Translational Sc | Apr 28, 2020 | Option Exercise | $0.27 | 2,530 | 683 | 51,056 | Apr 29, 2020, 05:56 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Translational Sc | Feb 18, 2020 | Option Exercise | $14.68 | 1,849 | 27,143 | 48,526 | Feb 20, 2020, 01:19 PM | |
| AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Translational Sc | Dec 18, 2019 | Option Exercise | $16.73 | 281 | 4,701 | 42,840 | Dec 20, 2019, 04:27 PM | |
| AXGN | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Translational Sc | Feb 15, 2019 | Option Exercise | $17.57 | 1,498 | 26,320 | 41,971 | Feb 19, 2019, 01:24 PM | |
| AXGN | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Translational Sc | Nov 13, 2018 | Option Exercise | $33.28 | 2,882 | 95,913 | 37,136 | Nov 15, 2018, 05:18 PM | |
| AXGN | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Translational Sc | Nov 13, 2018 | Option Exercise | $2.72 | 35,274 | 95,974 | 40,018 | Nov 15, 2018, 05:18 PM | |
| AXGN | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Translational Sc | Mar 14, 2017 | Option Exercise | $0.27 | 5,018 | 1,355 | 5,018 | Mar 14, 2017, 07:32 PM |
Menu